Seattle Genetics, Inc.

Seattle Genetics Inc. Presents at UBS Global Healthcare Conference, May-21-2013 11:30 AM

Market Report, "Seattle Genetics, Inc. - Product Pipeline Review - 2013", published

ABBV Does A Deal, INO Rises, DSCI On A New High, SGEN Gets PDUFA Date

Seattle Genetics announces ADCETRIS supplemental filing accepted by FDA

Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA

Seattle Genetics to Present at Upcoming Investor Conferences

BIOL Does A Deal, BLRX's Lined Up Events, CBST On Fast Track, KERX On Watch

Seattle Genetics reports Q1 EPS (14c), consensus (20c)

Seattle Genetics Reports First Quarter 2013 Financial Results

Bull’s Eye Report: Polycyclics (PCYC)